James M. Mock - 28 Feb 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
28 Feb 2025
Transactions value $
-$4,974
Form type
4
Filing time
03 Mar 2025, 16:49:50 UTC
Previous filing
28 Feb 2025
Next filing
07 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +329 +2.2% 15,034 28 Feb 2025 Direct F1
transaction MRNA Common Stock Tax liability -$4,974 -160 -1.1% $31.09 14,874 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -329 -11% $0 2,630 28 Feb 2025 Common Stock 329 Direct F1, F3
transaction MRNA Stock Option (Right to Buy) Award $0 +63,478 $0 63,478 01 Mar 2025 Common Stock 63,478 $30.96 Direct F4
transaction MRNA Restricted Stock Units Award $0 +39,606 $0 39,606 01 Mar 2025 Common Stock 39,606 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5 25% of the shares subject to this restricted stock unit award will vest on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.